Citation
64 FR 33309
Multiple canonical documents share this first-page citation.
- ``Draft Guidance for Industry: Current Good Manufacturing Practice for Blood and Blood Components: (1) Quarantine and Disposition of Prior Collections from Donors with Repeatedly Reactive Screening Tests for Hepatitis C Virus (HCV); (2) Supplemental Testing, and the Notification of Consignees and Transfusion Recipients of Donor Test Results for Antibody to HCV (Anti-HCV);'' Availability 64 FR 33309
- Registration and Listing Grassroots Meeting for Medical Device Manufacturers 64 FR 33309